Tchaikapharma High Quality Medicines AD
Develops and makes affordable generic drugs for cardiovascular & metabolic diseases.
THQM | BSOBGN
Overview
Corporate Details
- ISIN(s):
- BG1100008074
- LEI:
- 5299003VDHTK75D1JE38
- Country:
- Bulgaria
- Address:
- бул./ул. бул. Г.М.ДИМИТРОВ № 1, 1172 София
- Website:
- https://tchaikapharma.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Tchaikapharma High Quality Medicines AD is a pharmaceutical company focused on the development and manufacturing of affordable, high-quality generic and in-licensed medicines. The company's core expertise lies in producing cost-effective therapies for socially significant diseases. Its product portfolio covers several therapeutic areas, including cardiovascular, cerebrovascular, metabolic, and anti-inflammatory conditions. Tchaikapharma specializes in complex generics (polypills), aiming to improve treatment outcomes and increase patient access to modern healthcare solutions for both individuals and healthcare professionals.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-04-15 23:00 |
Annual / Quarterly Financial Statement
5299003VDHTK75D1JE38-20231231-BG-CON_CALCULATION-RES.html
|
English | 47.8 KB | ||
| 2024-04-15 23:00 |
Annual / Quarterly Financial Statement
609557-7TH_2023 CONS_BG_signed.xls
|
Bulgarian | 719.5 KB | ||
| 2024-04-15 23:00 |
Annual / Quarterly Financial Statement
609559-7TH_2023 CONS_EN_signed.xls
|
Bulgarian | 235.0 KB | ||
| 2024-04-15 23:00 |
Annual Report (ESEF)
609558-5299003VDHTK75D1JE38-20231231-EN-CON.zip
|
Bulgarian | 6.4 MB | ||
| 2024-03-26 23:00 |
Interim Report
608037-SPRAVKA_1_IND_GFO_6M.xls
|
Bulgarian | 722.0 KB | ||
| 2024-03-26 23:00 |
Management Discussion and Analysis
5299003VDHTK75D1JE38-20231231-BG-SEP.xhtml
|
Bulgarian | 21.8 MB | ||
| 2023-07-12 23:00 |
Regulatory News Service
7TH_2022 CONS_BG.xls
|
Bulgarian | 718.0 KB | ||
| 2023-06-07 23:00 |
Interim Report
SPRAVKA_1_IND_GFO_6M_signed.xls
|
Bulgarian | 778.5 KB | ||
| 2023-06-07 23:00 |
Annual Report
5299003VDHTK75D1JE38-20221231-BG-SEP.xhtml
|
Bulgarian | 37.0 MB | ||
| 2022-07-26 23:00 |
Annual / Quarterly Financial Statement
5299003VDHTK75D1JE38-20211231-BG-SEP.xhtml
|
Bulgarian | 5.7 MB | ||
| 2022-07-26 23:00 |
Annual / Quarterly Financial Statement
7TH_2021_signed.xls
|
Bulgarian | 939.0 KB | ||
| 2022-07-26 23:00 |
Annual Report (ESEF)
5299003VDHTK75D1JE38-20211231-BG-CON.zip
|
Bulgarian | 3.2 MB | ||
| 2022-07-26 23:00 |
Annual / Quarterly Financial Statement
7TH_2021 CONS.xls
|
Bulgarian | 900.0 KB |
Automate Your Workflow. Get a real-time feed of all Tchaikapharma High Quality Medicines AD filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Tchaikapharma High Quality Medicines AD via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
